| Legal Status: | Investigational |
| Cas Number: | 1971920-73-6 |
| Pubchem: | 124111565 |
| Drugbank: | DB18715 |
| Chemspiderid: | 88298633 |
| Unii: | 8CZ82ZYY9X |
| Kegg: | D12213 |
| Chembl: | 4650323 |
| Synonyms: | PRN2246; SAR-442168 |
| Iupac Name: | 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one |
| C: | 26 |
| H: | 25 |
| N: | 5 |
| O: | 3 |
| Smiles: | C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=NC=C3)N)N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5 |
| Stdinchi: | 1S/C26H25N5O3/c1-2-23(32)29-16-6-7-19(17-29)30-22-14-15-28-25(27)24(22)31(26(30)33)18-10-12-21(13-11-18)34-20-8-4-3-5-9-20/h2-5,8-15,19H,1,6-7,16-17H2,(H2,27,28)/t19-/m1/s1 |
| Stdinchikey: | KOEUOFPEZFUWRF-LJQANCHMSA-N |
Tolebrutinib is an investigational new drug that is being evaluated to treat multiple sclerosis.[1] It is a Bruton's tyrosine kinase (BTK) inhibitor.[2]